Free shipping on orders over 19,990 Ft via Packeta, Fox Post Box, and DPD Collection Point

Check order status

Become part of a community of book lovers from all over the world and get access to a whole bunch of benefits. Create an account for free

Free delivery for purchases over 19 990 Ft

DPD point 990 Ft DPD courier 1 190 Ft GLS point 1 190 Ft Hungarian Post 1 795 Ft Hungarian Post 1 690 Ft Hungarian Post 1 690 Ft FoxPost 1 190 Ft Packeta point 1 190 Ft GLS courier 1 690 Ft

Contact

How to shop

Help

My account

▸ Empty :-(

Free shipping on orders over 19,990 Ft via Packeta, Fox Post Box, and DPD Collection Point

Adenosinergic System

Name: Adenosinergic System
Brand: Springer International Publishing AG
SKU: 09301187
Price: 59222 HUF
Availability: InStock
Author: Micaela Morelli
ISBN: 9783319202723

A Non-Dopaminergic Target in Parkinson's Disease

Micaela Morelli

Nicola Simola

Jadwiga Wardas

Language

English

Book Hardback

Libristo code: 09301187

Publishers Springer International Publishing AG, September 2015

Adenosine A2A receptor antagonists have shown great promise in the treatment of Parkinson's Disease... Full description

Libristo code: 09301187

406 b

59 222 Ft

In stock at our supplier Shipping in 10-13 days

Up to 30 days for returns

Customers also purchased

Workshop Kunst Herbert Schöttle

Paperback

16 025 Ft

alfabeto simbolico degli animali Francesco Zambon

Paperback

9 518 Ft

La batalla de Francia 50Minutos

Adobe ePub DRM

4 059 Ft

Otto Placht - Sol Silvestre Otto Placht

Paperback

2 527 Ft

Měla by to být blondýnka s modrýma očima/Blondinka s golubymi glazami Anton Pavlovič Čechov

Hardback

1 620 Ft

Die Reise einer jungen Anarchistin in Griechenland. Marlene Streeruwitz

Paperback

3 530 Ft

Mein Mathebuch - Ausgabe B für Bayern - 3. Jahrgangsstufe Brigitte Dangelat-Bergner

Paperback

4 496 Ft

Verteilungsverfahren Ferdinand Wollenschläger

Hardback

55 941 Ft

Adenosine A2A receptor antagonists have shown great promise in the treatment of Parkinson's Disease and alleviation of symptoms. This book addresses various aspects of this class of drugs from their chemical development to their clinical use. Among the many insightful chapters contained in this book, there are three unique reviews that have not previously been published in any format: (1) a history of istradefylline, the first A2A antagonist approved for treatment of Parkinson's Disease, (2) an overview of neuroimaging studies in human death and disease, and (3) a study of urate as a possible biomarker and neuroprotectant.